Dec 31, 2018

Blueprint Medicines Q4 2018 Earnings Report

Total Revenue
$1.03M
Previous year: $1.63M
-36.5%
EPS
-$1.83
Previous year: -$1.23
+48.8%
Gross Profit
-$69.5M
Cash and Equivalents
$68.1M
Free Cash Flow
-$68M
Total Assets
$540M

Blueprint Medicines

Blueprint Medicines